Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2)

Igho J. Onakpoya; Carl J. Heneghan; Jeffrey K. Aronson

ArticleOPEN ACCESS

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2)

Onakpoya I
Heneghan C
Aronson J

BMC Medicine

DOI: 10.1186/s12916-019-1294-9

8Citations

9Readers

Abstract

The original article [1] contains a minor error whereby the dates for year of first launch and year of first report of adverse reaction for iophendylate in e-Appendix Table 1 are mistakenly presented as 1946 and 1975 respectively.

Cite

CITATION STYLE

APA

Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2019, March 2). Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2). BMC Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12916-019-1294-9

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature (BMC Med. (2016) 14 (10) DOI: 10.1186/s12916-016-0553-2)

Abstract

Cite

Register to see more suggestions